Kymera Therapeutics Inc (KYMR)

09:43 AM

Custom strategy builders for tracking Kymera Therapeutics Inc.2025 Market Trends & Risk Adjusted Swing Trade Ideas - newser.com

09:43 AM

07:59 AM

What earnings revisions data tells us about Kymera Therapeutics Inc.Sell Signal & Safe Entry Momentum Tips - newser.com

07:59 AM

05:44 AM

Is Kymera Therapeutics Inc. stock attractive for ETFsEarnings Performance Report & Verified Short-Term Plans - newser.com

05:44 AM

01:30 AM

Will Kymera Therapeutics Inc. see short term momentumOptions Play & AI Powered Market Entry Strategies - newser.com

01:30 AM

01:11 AM

What’s the recovery path for long term holders of Kymera Therapeutics Inc.2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com

01:11 AM

Oct 10, 2025

Kymera Therapeutics Inc Stock Analysis and ForecastSupport and Resistance Levels & Free Stock Market Mentorship Programs - earlytimes.in

Oct 10, 2025

Oct 10, 2025

Full technical analysis of Kymera Therapeutics Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Kymera Therapeutics (NASDAQ:KYMR) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

Kymera Therapeutics Inc. stock chart pattern explainedFed Meeting & Daily Chart Pattern Signal Reports - newser.com

Oct 10, 2025

Oct 09, 2025

Ranking Kymera Therapeutics Inc. among high performing stocks via toolsWeekly Market Report & Risk Controlled Swing Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Should you hold or exit Kymera Therapeutics Inc. nowJuly 2025 Institutional & Real-Time Stock Movement Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Top chart patterns to watch in Kymera Therapeutics Inc.Market Trend Review & Community Verified Watchlist Alerts - newser.com

Oct 09, 2025

Oct 06, 2025

Kymera Therapeutics Hits New 52-Week High of $59.00, Up 69% - Markets Mojo

Oct 06, 2025

Oct 06, 2025

Analyzing net buyer seller activity in Kymera Therapeutics Inc.Sell Signal & High Yield Stock Recommendations - newser.com

Oct 06, 2025

Oct 06, 2025

Will Kymera Therapeutics Inc. stock maintain momentum in 20252025 Market WrapUp & Safe Capital Allocation Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Tools to monitor Kymera Therapeutics Inc. recovery probabilityMarket Growth Summary & Capital Protection Trading Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Keudell Morrison Wealth Management Invests $334,000 in Kymera Therapeutics, Inc. $KYMR - MarketBeat

Oct 05, 2025

Oct 03, 2025

Kymera Therapeutics stock hits 52-week high at $58.97 By Investing.com - Investing.com Nigeria

Oct 03, 2025

Oct 03, 2025

Kymera Therapeutics stock hits 52-week high at $58.97 - Investing.com

Oct 03, 2025

Oct 03, 2025

What analysts say about Kymera Therapeutics Inc stockGlobal Trade Effects & Low Risk Capital Growth Plans - earlytimes.in

Oct 03, 2025

Oct 03, 2025

Analysts Set Kymera Therapeutics, Inc. (NASDAQ:KYMR) PT at $59.95 - Defense World

Oct 03, 2025

Oct 02, 2025

Real time pattern detection on Kymera Therapeutics Inc. stockMarket Activity Summary & Consistent Profit Focused Trading Strategies - newser.com

Oct 02, 2025

Oct 02, 2025

Kymera Therapeutics (NASDAQ:KYMR) Given New $68.00 Price Target at Truist Financial - Defense World

Oct 02, 2025

Oct 01, 2025

Oppenheimer Maintains Kymera Therapeutics (KYMR) Outperform Recommendation - Nasdaq

Oct 01, 2025

Oct 01, 2025

Kymera Therapeutics Hits New 52-Week High of $58.93, Up 65.21% - Markets Mojo

Oct 01, 2025

Oct 01, 2025

Is Codere Online Luxembourg SA a good long term investmentVolume Weighted Average Price & Learn the Basics of Investing in 5 Days - earlytimes.in

Oct 01, 2025

Oct 01, 2025

Oppenheimer Raises Price Target for Kymera Therapeutics (KYMR) t - GuruFocus

Oct 01, 2025

Oct 01, 2025

Kymera Overcomes Sanofi Deal Update, Marches Ahead With Pipeline - Nasdaq

Oct 01, 2025

Oct 01, 2025

Oppenheimer Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Maintains Target Price $63 - 富途牛牛

Oct 01, 2025

Oct 01, 2025

Kymera Therapeutics (NASDAQ:KYMR) Hits New 52-Week High Following Analyst Upgrade - Defense World

Oct 01, 2025

Sep 30, 2025

Truist Securities raises Kymera Therapeutics stock price target to $68 on KT-621 potential - Investing.com Canada

Sep 30, 2025

Sep 30, 2025

Truist Securities Boosts KYMR Price Target by Over 28% | KYMR Stock News - GuruFocus

Sep 30, 2025

Sep 30, 2025

Truist Financial Raises Kymera Therapeutics (NASDAQ:KYMR) Price Target to $68.00 - MarketBeat

Sep 30, 2025

Sep 30, 2025

Truist Raises Price Target on Kymera Therapeutics to $68 From $53, Keeps Buy Rating - MarketScreener

Sep 30, 2025

Sep 30, 2025

Truist Financial Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Announces Target Price $68 - 富途牛牛

Sep 30, 2025

Sep 30, 2025

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Sep 30, 2025

Sep 30, 2025

Published on: 2025-09-30 02:20:06 - newser.com

Sep 30, 2025

Sep 29, 2025

Kymera Therapeutics Hits New 52-Week High of $56.81, Up 64% Year-to-Date - Markets Mojo

Sep 29, 2025

Sep 29, 2025

Kymera Therapeutics (KYMR): Revisiting Valuation After Recent Share Price Momentum - Yahoo Finance

Sep 29, 2025

Sep 28, 2025

Kymera Therapeutics Gains Momentum with Price Target Upgrades - timothysykes.com

Sep 28, 2025

Sep 28, 2025

Is Kymera Therapeutics Inc a good long term investmentSector Performance Review & Affordable Portfolio Building - earlytimes.in

Sep 28, 2025

Sep 28, 2025

Kymera Therapeutics Price Target Boosted Amid Promising Clinical Data - timothysykes.com

Sep 28, 2025